A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China

Summary

The main goal of this study is to evaluate the effect of dostarlimab monotherapy in Chinese participants with locally advanced Mismatch-repair deficient (dMMR)/ Microsatellite instability-high (MSI-H) rectal cancer who have received no prior treatment.

Timeline

Start

2024-10-17

Primary completion

2027-10-24

Completion

2031-04-15

Drugs

Indications